Skip to main content
Top
Published in: Infection 5/2019

01-10-2019 | Streptococci | Original Paper

Septic arthritis due to streptococci and enterococci in native joints: a 13 year retrospective study

Authors: Helene Lotz, Carol Strahm, Vilijam Zdravkovic, Bernhard Jost, Werner C. Albrich

Published in: Infection | Issue 5/2019

Login to get access

Abstract

Objectives

Streptococcal species are the second most common cause of native joint septic arthritis (SA). However, there are few systematic data about streptococcal SA.

Methods

The medical records of adults with SA caused by streptococci, pneumococci, and enterococci at our tertiary care centre between 2003 and 2015 were reviewed.

Results

71 patients (34% female) with 83 affected joints were included. Median age was 62 years. A single joint was involved in 62 patients (87%). One or more comorbidities were present in 58 patients (82%). 16 patients (23%) had a concomitant soft-tissue infection overlying the affected joint. The hematogenous route was the dominating pathogenesis (42/71, 59%). 9 (13%) patients were diagnosed with endocarditis. The knee was the most commonly affected joint (27/83, 33%) followed by shoulder (13/83, 16%). ß-haemolytic streptococci were most commonly identified (37/71, 52%) followed by polymicrobial infections (12/71, 17%). Surgical interventions included arthroscopic irrigation and debridement in 31 (44%), arthrotomy in 23 (32%), and amputation in five patients (7%). Median duration of antimicrobial therapy was 42 days. Antibiotic treatment without any surgical intervention was performed in 5 (7%) patients. Outcome was good in 55 (89%) patients; mortality was 13% with four of nine deaths attributed to joint infection. Age and pathogen group independently predicted poor outcome in recursive partitioning analysis.

Conclusions

Streptococcal SA was mostly due to ß-haemolytic streptococci in older and polymorbid patients. Old age, anginosus group streptococci, enterococci, and polymicrobial infections predicted poor outcome, while antibiotic treatment duration can likely be shortened.
Appendix
Available only for authorised users
Literature
4.
go back to reference Kaandorp CJ, Van Schaardenburg D, Krijnen P, Habbema JD, van de Laar MA. Risk factors for septic arthritis in patients with joint disease. A prospective study. Arthritis Rheum. 1995;38:1819–25.CrossRef Kaandorp CJ, Van Schaardenburg D, Krijnen P, Habbema JD, van de Laar MA. Risk factors for septic arthritis in patients with joint disease. A prospective study. Arthritis Rheum. 1995;38:1819–25.CrossRef
8.
go back to reference Osiri M, Akkasilpa S, Reinprayoon S, Deesomchok U. Streptococcal arthritis in Thai adults: case series and review. J Med Assoc Thai. 1996;79:755–61.PubMed Osiri M, Akkasilpa S, Reinprayoon S, Deesomchok U. Streptococcal arthritis in Thai adults: case series and review. J Med Assoc Thai. 1996;79:755–61.PubMed
16.
go back to reference Nolla JM, Gomez-Vaquero C, Corbella X, Ordonez S, Garcia-Gomez C, Perez A, et al. Group B streptococcus (Streptococcus agalactiae) pyogenic arthritis in nonpregnant adults. Medicine (Baltimore). 2003;82:119–28.CrossRef Nolla JM, Gomez-Vaquero C, Corbella X, Ordonez S, Garcia-Gomez C, Perez A, et al. Group B streptococcus (Streptococcus agalactiae) pyogenic arthritis in nonpregnant adults. Medicine (Baltimore). 2003;82:119–28.CrossRef
18.
go back to reference Schattner A, Vosti KL. Bacterial arthritis due to beta-hemolytic streptococci of serogroups A, B, C, F, and G. Analysis of 23 cases and a review of the literature. Medicine (Baltimore). 1998;77:122–39.CrossRef Schattner A, Vosti KL. Bacterial arthritis due to beta-hemolytic streptococci of serogroups A, B, C, F, and G. Analysis of 23 cases and a review of the literature. Medicine (Baltimore). 1998;77:122–39.CrossRef
19.
go back to reference Ortel TL, Kallianos J, Gallis HA. Group C streptococcal arthritis: case report and review. Rev Infect Dis. 1990;12:829–37.CrossRef Ortel TL, Kallianos J, Gallis HA. Group C streptococcal arthritis: case report and review. Rev Infect Dis. 1990;12:829–37.CrossRef
20.
go back to reference Laster AJ, Michels ML. Group B streptococcal arthritis in adults. Am J Med. 1984;76:910–5.CrossRef Laster AJ, Michels ML. Group B streptococcal arthritis in adults. Am J Med. 1984;76:910–5.CrossRef
22.
go back to reference Pioro MH, Mandell BF. Septic arthritis. Rheum Dis Clin North Am. 1997;23:239–58.CrossRef Pioro MH, Mandell BF. Septic arthritis. Rheum Dis Clin North Am. 1997;23:239–58.CrossRef
23.
go back to reference Shirtliff ME, Mader JT. Acute septic arthritis. Clin Microbiol Rev. 2002;15:527–44.CrossRef Shirtliff ME, Mader JT. Acute septic arthritis. Clin Microbiol Rev. 2002;15:527–44.CrossRef
27.
33.
go back to reference Smith JW, Piercy EA. Infectious arthritis. Clin Infect Dis. 1995;20:225–30 (quiz 31) CrossRef Smith JW, Piercy EA. Infectious arthritis. Clin Infect Dis. 1995;20:225–30 (quiz 31) CrossRef
34.
go back to reference Stutz G, Gachter A. Diagnosis and stage-related therapy of joint infections. Unfallchirurg. 2001;104:682–6.CrossRef Stutz G, Gachter A. Diagnosis and stage-related therapy of joint infections. Unfallchirurg. 2001;104:682–6.CrossRef
Metadata
Title
Septic arthritis due to streptococci and enterococci in native joints: a 13 year retrospective study
Authors
Helene Lotz
Carol Strahm
Vilijam Zdravkovic
Bernhard Jost
Werner C. Albrich
Publication date
01-10-2019
Publisher
Springer Berlin Heidelberg
Published in
Infection / Issue 5/2019
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-019-01301-w

Other articles of this Issue 5/2019

Infection 5/2019 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.